Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
NCT02015806
Basal Ganglia Diseases, Behavior
Woonsocket, Rhode Island, United States
View Trial DetailsNCT Number: NCT06981689
Female breast cancer patients who underwent total mastectomy followed by breast reconstruction
Looking for future studies?
Notify Me18 year and older
Female
Observational
Female breast cancer patients who underwent total mastectomy followed by breast reconstruction
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year, 5 year and 9 year since surgery
The primary endpoint was clinically diagnosed psychiatric disorder, defined as the first occurrence of a diagnosis made by a physician for any of the following major psychiatric conditions: anxiety disorders (F40, F41), bipolar disorder (F30, F31, F34.0), depressive disorders (F32, F33), sleep disorders (G47.0, F51.0), obsessive-compulsive disorder (F42), posttraumatic stress disorder (F43.1), and substance use disorders (F10-F19).
Samsung Medical Center
Other
Association of Breast Reconstruction Method With Long-term Risk of Psychiatric Disorders: A Target Trial Emulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02015806
Basal Ganglia Diseases, Behavior
Woonsocket, Rhode Island, United States
View Trial DetailsNCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial Details